|
|
OPEN ACCESS ARTICLE |
| p24 |
Nitric oxide (NO) enhances pemetrexed cytotoxicity via NO‑cGMP signaling in lung adenocarcinoma cells in vitro and in vivo |
Hiroki Nagai, Hiroyasu Yasuda, Yukimasa Hatachi, Deng Xue, Takahiko Sasaki, Mutsuo Yamaya, Yuichi Sakamori, Yousuke Togashi, Katsuhiro Masago, Isao Ito, Young Hak Kim, Tadashi Mio, Michiaki Mishima
|
|
|
|
| p61 |
PSK induces apoptosis through the inhibition of activated STAT3 in human esophageal carcinoma cells |
Seiji Umehara, Hitoshi Fujiwara, Atsushi Shiozaki, Momoko Todo, Akinobu Furutani, Masayuki Yoneda, Atsushi Ikai, Hiroyuki Tada, Shuhei Komatsu, Daisuke Ichikawa, Kazuma Okamoto, Toshiya Ochiai, Yukihito Kokuba, Eigo Otsuji
|
|
|
|
| p76 |
Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1 |
Yong Sang Hong, Seung-Woo Hong, Seung-Mi Kim, Dong-Hoon Jin, Jae-Sik Shin, Dok Hyun Yoon, Kyu-Pyo Kim, Jae-Lyun Lee, Dae Seog Heo, Jung Shin Lee, Tae Won Kim
|
|
|
|
| p83 |
Valproic acid cooperates with hydralazine to augment the susceptibility of human osteosarcoma cells to Fas- and NK cell-mediated cell death |
Koji Yamanegi, Junko Yamane, Kenta Kobayashi, Nahoko Kato-Kogoe, Hideki Ohyama, Keiji Nakasho, Naoko Yamada, Masaki Hata, Satoru Fukunaga, Hiroyuki Futani, Haruki Okamura, Nobuyuki Terada
|
|
|
|
| p92 |
Identification of potential prognostic biomarkers for node-negative breast tumours by proteomic analysis: A multicentric 2004 national PHRC study |
Françoise Descotes, Pascal Jézéquel, Frédérique Spyratos, Loïc Campion, Catherine Grenot, Florence Lerebours, Mario Campone, Catherine Guérin-Charbonnel, Didier Lanoë, Marjorie Adams, Jean André, Antoine Carlioz, Pierre-Marie Martin, Agnès Chassevent, Marie-Lise Jourdan, Catherine Guette, Isabelle Zanella-Cleon, Gabriel Ricolleau
|
|
|
|
| p117 |
Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy |
Arianna Citti, Renata Boldrini, Alessandro Inserra, Anna Alisi, Rosanna Pessolano, Angela Mastronuzzi, Angelica Zin, Luigi De Sio, Angelo Rosolen, Franco Locatelli, Doriana Fruci
|
|
|
|
| p135 |
A novel gene expression system for detecting viable bladder cancer cells |
Hideo Ueki, Masami Watanabe, Haruki Kaku, Peng Huang, Shun-Ai Li, Kazuhiko Ochiai, Takeshi Hirata, Hirofumi Noguchi, Hiroshi Yamada, Kohji Takei, Yasutomo Nasu, Yuji Kashiwakura, Hiromi Kumon
|
|
|
|
| p147 |
Assessment of EGFR and K-ras mutations in fixed and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small cell lung cancer patients |
Paola Ulivi, Micaela Romagnoli, Elisa Chiadini, Gian-Luca Casoni, Laura Capelli, Carlo Gurioli, Wainer Zoli, Luca Saragoni, Alessandra Dubini, Anna Tesei, Dino Amadori, Venerino Poletti
|
|
|
|
| p161 |
Hypoxia upregulates Hsp90α expression via STAT5b in cancer cells |
Se Hyung Pak, Youn Hee Joung, Jin Hee Park, Eun Joung Lim, Pramod Darvin, Yoon Mi Na, Dae Young Hong, Boram Lee, Tae Sook Hwang, Taegyu Park, Sang-Kyu Ye, Eon-Soo Moon, Byung Wook Cho, Kyung Do Park, Hak Kyo Lee, Ill-Min Chung, Young Mok Yang
|
|
|
|
| p179 |
The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer |
Nadim Bou Zgheib, Yin Xiong, Douglas C. Marchion, Elona Bicaku, Hye Sook Chon, Xiaomang Ba Stickles, Entidhar Al Sawah, Patricia L. Judson, Ardeshir Hakam, Jesus Gonzalez-Bosquet, Robert M. Wenham, Sachin M. Apte, Christopher L. Cubitt, Dung Tsa Chen, Johnathan M. Lancaster
|
|
|
|
| p189 |
Identification of a GαGβγ, AKT and PKCα signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition |
Radia Ouelaa-Benslama, Olivier De Wever, An Hendrix, Michèle Sabbah, Kathleen Lambein, David Land, Grégoire Prévost, Marc Bracke, Mien-Chie Hung, Annette K. Larsen, Shahin Emami, Christian Gespach
|
|
|
|
| p235 |
PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma |
M. C. Burger, D. P. Brucker, P. Baumgarten, M. W. Ronellenfitsch, C. Wanka, M. Hasselblatt, M. R. Eccles, T. Klingebiel, M. Weller, J. Rieger, M. Mittelbronn, J. P. Steinbach
|
|
|
|
| p242 |
Progressive lung cancer determined by expression profiling and transcriptional regulation |
Namshik Han, Zulkifli Dol, Olga Vasieva, Russell Hyde, Triantafillos Liloglou, Olaide Raji, Elisabeth Brambilla, Christian Brambilla, Yves Martinet, Gabriella Sozzi, Angela Risch, Luis M. Montuenga, The EUELC Consortium, Andy Brass, John K. Field
|
|
|
|
| p253 |
Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma |
Takehiko Yokobori, Koshi Mimori, Masaaki Iwatsuki, Hideshi Ishii, Fumiaki Tanaka, Tetsuya Sato, Hiroyuki Toh, Tomoya Sudo, Takeshi Iwaya, Yoichi Tanaka, Ichiro Onoyama, Hiroyuki Kuwano, Keiichi I. Nakayama, Masaki Mori
|
|
|
|
| p317 |
ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines |
Cristina Teixidó, Elisabet Arguelaguet, Berta Pons, Miguel Aracil, Jose Jimeno, Rosa Somoza, Roso Marés, Santiago Ramón y Cajal, Javier Hernández-Losa
|
|
|
|
|
|
